-+ 0.00%
-+ 0.00%
-+ 0.00%

ANGELINI PHARMA TO ACQUIRE CATALYST PHARMACEUTICALS FOR 4.1 BILLION USD (3.5 BILLION EUROS), ENTERING THE U.S. MARKET AND CONSOLIDATING ITS LEADERSHIP IN BRAIN HEALTH AND RARE DISEASE

Reuters·05/07/2026 07:25:36

Please log in to view news